NSC
60
3
HAS
33
3
LMT
34
2
YUM
47
3
CAH
48
-5
PRGO
39
3
NOC
43
11
ILMN
42
5
LLY
37
-3
EMN
60
4
CSCO
67
4
MCHP
41
4
HCA
44
-2
EL
25
4
USB
55
-6
MET
72
5
IR
66
3
CF
57
-2
SIG
52
3
MA
64
7
NSC
60
3
HAS
33
3
LMT
34
2
YUM
47
3
CAH
48
-5
PRGO
39
3
NOC
43
11
ILMN
42
5
LLY
37
-3
EMN
60
4
CSCO
67
4
MCHP
41
4
HCA
44
-2
EL
25
4
USB
55
-6
MET
72
5
IR
66
3
CF
57
-2
SIG
52
3
MA
64
7
Financhill
Back

Range Cancer Therapeutics ETF Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

CNCR
Range Cancer Therapeutics ETF

Last Price:
13.62
Seasonality Move:
2.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Range Cancer Therapeutics ETF Price Quote

$13.62
+0.06 (+3.03%)
(Updated: November 23, 2024 at 5:30 AM ET)

Range Cancer Therapeutics ETF Key Stats

Sell
47
Range Cancer Therapeutics ETF (CNCR) is a Sell
Day range:
$13.28 - $13.70
52-week range:
$10.49 - $17.96
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
3.6K
Avg. volume:
3.6K
1-year change:
29.2%
Market cap:
$0
Revenue:
$0
EPS:
$0

How Much Does Range Cancer Therapeutics ETF Make?

Data Unavailable

Is Range Cancer Therapeutics ETF Growing As A Company?

Data Unavailable

Range Cancer Therapeutics ETF Stock Price Performance

What Is Range Cancer Therapeutics ETF 52-Week High & Low?

Range Cancer Therapeutics ETF Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Range Cancer Therapeutics ETF?

Data Unavailable

Is Range Cancer Therapeutics ETF Cash Flow Positive?

Data Unavailable

Range Cancer Therapeutics ETF Return On Invested Capital

Data Unavailable

Range Cancer Therapeutics ETF Earnings Date & Stock Price

Range Cancer Therapeutics ETF Competitors

  • Who Are Range Cancer Therapeutics ETF's Competitors?
    Below is a list of companies who compete with Range Cancer Therapeutics ETF or are related in some way:
    • Virtus LifeSci Biotech Clinical Trls ETF (BBC)
    • Virtus LifeSci Biotech Products ETF (BBP)
    • First Trust Nasdaq Pharmaceuticals ETF (FTXH)
    • SPDR® S&P Health Care Services ETF (XHS)
    • SPDR® S&P Pharmaceuticals ETF (XPH)

Range Cancer Therapeutics ETF Dividend Yield

Range Cancer Therapeutics ETF Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable